Greenstreet Yvonne bought ALNY
November 12, 2025 · Form 4 insider transaction
Greenstreet Yvonne bought 650 shares of Alnylam Pharmaceuticals, Inc. at $42.22 per share, a transaction worth $27.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
650
Price
$42.22
Total value
$27.4K
InsiderGreenstreet Yvonne
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 12, 2025
Filing dateNovember 14, 2025
Shares owned after66,059
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 13, 2025.